A Turnaround in Sight for Healthcare?
Our U.S. Biotech and Biopharma analysts Sean Laaman and Terence Flynn discuss the latest developments that could be positioning the healthcare sector for strong outperformance. Read more insights from Morgan Stanley. ----- Transcript ----- Sean Laaman: Welcome to Thoughts on the Market. I'm Sean Laaman, Morgan…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Thoughts on the Market →
Stocks Stage A Reversal.. And The Latest Health Care M&A 11/14/25
Here Comes the Booming Chinese Biotech Sector
Longevity: Can We Add Another 30 Years? | The Decade Ahead
54%Where to find healthy profits in biotech
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.